2023 Best of Lung: Targeted Therapies in Lung Cancer
Вставка
- Опубліковано 3 січ 2025
- In this session from the Total Health 2023 Best of Lung conference, Dr Jaime Schneider from Massachusetts General Hospital Cancer Center discusses the use of targeted treatments in lung cancer.
In ros 1 nsclc which medicine is best crizotinib or ceritinib?
Squamous cell carcinoma alk positive cancer me best ky h
ALK positive is very rare in squamous cell carcinoma. But may happen in females and non smokers.
Best treatment is a group of drug called ALK TKI. Lorlatinib, Alectinib are the best among them.
Informative. But you speak very fast. Closed captioning can’t keep up. I’m trying to learn from this seminar but can’t decipher all of what you are saying. I will have to watch this video at leastc2 times. Thank you for your information about Tagrisso and NSCLC.
If you go to settings on top right you can control speed.
So with squamous nsclc my best bet after radiation,chemo,and immuni therapy is I’m still looking at a year at best
So live that year to the best!
So live that year to the best
You ll live long much longer
TKI side effects?!
Very good question TKI they'll definitely impact other areas of the body it's a diversified kinase.